celecoxib has been researched along with Labor, Premature in 7 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Celecoxib administration for more than 48 hours in the second trimester of pregnancy might be safe and tolerable in terms of fetal PSV-DA and amniotic fluid volume as long as careful ultrasound monitoring is performed." | 8.12 | The effect of celecoxib for treatment of preterm labor on fetuses during the second trimester of pregnancy: A pilot case series. ( Chigusa, Y; Kawasaki, K; Kondoh, E; Mandai, M; Mogami, H; Ohtsuki, M; Ueda, A; Yamaguchi, K, 2022) |
| "Celecoxib administration for more than 48 hours in the second trimester of pregnancy might be safe and tolerable in terms of fetal PSV-DA and amniotic fluid volume as long as careful ultrasound monitoring is performed." | 4.12 | The effect of celecoxib for treatment of preterm labor on fetuses during the second trimester of pregnancy: A pilot case series. ( Chigusa, Y; Kawasaki, K; Kondoh, E; Mandai, M; Mogami, H; Ohtsuki, M; Ueda, A; Yamaguchi, K, 2022) |
| "To analyse the expression of 15 genes encoding receptors and enzymes associated with the molecular mechanism of the tocolytic drugs atosiban (oxytocin receptor antagonist), nifedipine (calcium channel blocker) and celecoxib (selective cyclo-oxygenase-2 inhibitor) in preterm labor patients with premature rupture of fetal membranes in relation to symptoms of intrauterine infection and preterm labor risk factors." | 3.78 | Expression of selected genes in preterm premature rupture of fetal membranes. ( Chyczewski, L; Kowalczuk, O; Kuć, P; Laudański, P; Laudański, T, 2012) |
| "We aimed to use celecoxib to suppress preterm labor instead magnesium sulfate (MgSO4) to prevent preterm labor." | 2.79 | Using celecoxib for the suppression of preterm labor instead of magnesium sulfate. ( Cheraghi, M; Moramezi, F; Saadati, N; Sokhray, L, 2014) |
| " There were no significant maternal or neonatal adverse events." | 2.70 | A prospective randomized safety trial of celecoxib for treatment of preterm labor. ( Bernhard, LM; Gerber, S; Gross, GA; Leguizamon, G; Levy, R; Mathur, A; Nelson, DM; Sadovsky, Y; Stika, CS, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Ohtsuki, M | 1 |
| Chigusa, Y | 1 |
| Mogami, H | 1 |
| Ueda, A | 1 |
| Kawasaki, K | 1 |
| Yamaguchi, K | 1 |
| Mandai, M | 1 |
| Kondoh, E | 1 |
| Saadati, N | 1 |
| Moramezi, F | 1 |
| Cheraghi, M | 1 |
| Sokhray, L | 1 |
| Kuć, P | 1 |
| Laudański, P | 1 |
| Kowalczuk, O | 1 |
| Chyczewski, L | 1 |
| Laudański, T | 1 |
| Stika, CS | 1 |
| Gross, GA | 1 |
| Leguizamon, G | 1 |
| Gerber, S | 1 |
| Levy, R | 1 |
| Mathur, A | 1 |
| Bernhard, LM | 1 |
| Nelson, DM | 1 |
| Sadovsky, Y | 1 |
| Hartleroad, JY | 1 |
| Beharry, KD | 1 |
| Hausman, N | 1 |
| Stavitsky, Y | 1 |
| Asrat, T | 1 |
| Modanlou, HD | 1 |
| Borna, S | 1 |
| Saeidi, FM | 1 |
| Sakai, M | 1 |
| Tanebe, K | 1 |
| Sasaki, Y | 1 |
| Momma, K | 1 |
| Yoneda, S | 1 |
| Saito, S | 1 |
3 trials available for celecoxib and Labor, Premature
| Article | Year |
|---|---|
Using celecoxib for the suppression of preterm labor instead of magnesium sulfate.
Topics: Adult; Celecoxib; Female; Gestational Age; Humans; Magnesium Sulfate; Obstetric Labor, Premature; Pa | 2014 |
A prospective randomized safety trial of celecoxib for treatment of preterm labor.
Topics: Adolescent; Adult; Celecoxib; Cyclooxygenase Inhibitors; Double-Blind Method; Female; Humans; Indome | 2002 |
Celecoxib versus magnesium sulfate to arrest preterm labor: randomized trial.
Topics: Adult; Birth Weight; Celecoxib; Cyclooxygenase 2 Inhibitors; Female; Gestational Age; Humans; Infant | 2007 |
4 other studies available for celecoxib and Labor, Premature
| Article | Year |
|---|---|
The effect of celecoxib for treatment of preterm labor on fetuses during the second trimester of pregnancy: A pilot case series.
Topics: Celecoxib; Cyclooxygenase 2 Inhibitors; Ductus Arteriosus; Female; Humans; Infant; Infant, Newborn; | 2022 |
Expression of selected genes in preterm premature rupture of fetal membranes.
Topics: Adult; Calcium Channel Blockers; Calcium Channels, L-Type; Celecoxib; Cyclooxygenase 2 Inhibitors; D | 2012 |
Effect of maternal administration of selective cyclooxygenase (COX)-2 inhibitors on renal size, growth factors, proteinases, and COX-2 secretion in the fetal rabbit.
Topics: Animals; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Female | 2005 |
Evaluation of the tocolytic effect of a selective cyclooxygenase-2 inhibitor in a mouse model of lipopolysaccharide-induced preterm delivery.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Chorioamnionitis; Cyclooxygenase 2; Cyc | 2001 |